Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report

A young woman presenting with an ovarian immature teratoma (stage IA, grade 2) demonstrates the dilemma associated with the decision to withhold adjuvant chemotherapy of documented clinical utility in a setting where highly effective treatment is available should the cancer ultimately recur.

Detalles Bibliográficos
Autor principal: Markman, Maurie
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: July 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920005/
https://www.ncbi.nlm.nih.gov/pubmed/20740202
http://dx.doi.org/10.1159/000318532
_version_ 1782185231070003200
author Markman, Maurie
author_facet Markman, Maurie
author_sort Markman, Maurie
collection PubMed
description A young woman presenting with an ovarian immature teratoma (stage IA, grade 2) demonstrates the dilemma associated with the decision to withhold adjuvant chemotherapy of documented clinical utility in a setting where highly effective treatment is available should the cancer ultimately recur.
format Text
id pubmed-2920005
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-29200052010-08-25 Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report Markman, Maurie Case Rep Oncol Published: July 2010 A young woman presenting with an ovarian immature teratoma (stage IA, grade 2) demonstrates the dilemma associated with the decision to withhold adjuvant chemotherapy of documented clinical utility in a setting where highly effective treatment is available should the cancer ultimately recur. S. Karger AG 2010-07-10 /pmc/articles/PMC2920005/ /pubmed/20740202 http://dx.doi.org/10.1159/000318532 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: July 2010
Markman, Maurie
Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
title Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
title_full Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
title_fullStr Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
title_full_unstemmed Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
title_short Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
title_sort withholding recognized effective adjuvant anti-neoplastic chemotherapy in a setting with known highly active treatment for recurrent disease: a case report
topic Published: July 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920005/
https://www.ncbi.nlm.nih.gov/pubmed/20740202
http://dx.doi.org/10.1159/000318532
work_keys_str_mv AT markmanmaurie withholdingrecognizedeffectiveadjuvantantineoplasticchemotherapyinasettingwithknownhighlyactivetreatmentforrecurrentdiseaseacasereport

Ejemplares similares